Characteristics of inflammation common to both diabetes and periodontitis: Are predictive diagnosis and targeted preventive measures possible?

EPMA Journal

Volumn 1, Issue 1, 2010, Pages 101-116

  Hanes, Philip J ^a   Krishna, Ranjitha ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Biomarkers; Diabetes; Gingival crevicular fluid; Individualized treatment; Inflammation; Periodontitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLLAGENASE; FIBRINOGEN; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEINASE; STRUCTURAL PROTEIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BLOOD GLUCOSE MONITORING; CHRONIC PERIODONTITIS; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GINGIVA BLEEDING; GINGIVITIS; GLUCOSE BLOOD LEVEL; HUMAN; PERIODONTAL EXAMINATION; PERSONALIZED MEDICINE; PREDICTION; PREVENTION STUDY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 79960053122     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0016-3     Document Type: Review

References (150)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89-95.
2. Mealey B, Rees T, Rose L. Systemic factors impacting the periodontium. In: Rose L, Mealey B, editors. Periodontics medicine, surgery, and implants. St. Louis: Elsevier Mosby; 2004.
3. Loe H. Periodontal disease: The sixth complication of diabetes mellitus. Diabetes Care. 1993;16 Suppl 1:329-34.
4. Mealey B, Oates T. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77:1289-303.
5. Papapanou P. Periodontal diseases: epidemiology. Ann Periodontol. 1996;1:1-36.
6. Bacic M, Plancak D, Granic M. CPITN assessment of periodontal status in diabetic patients. J Periodontol. 1988;59:816-22.
7. Emrich L, Shlossman M, Genco R. Periodontal disease in noninsulin dependent diabetesmellitus. J Periodontol. 1991;62:123-31.
8. Shlossman M, Knowler W, Pettitt D, et al. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990;121:532-6.
9. Tervonen T, Oliver R. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol. 1993;20:431-5.
10. Gusberti F, Syed S, Bacon G, et al. Puberty gingivitis in insulindependent diabetic children. I. Cross-sectional observations. J Periodontol. 1983;54:714-20.
11. Sastrowijoto S, van der Velden U, van Steenbergen T, et al. Improved metabolic control, clinical periodontal status, and subgingival microbiology in insulin-dependent diabetes mellitus. A prospective study. J Clin Periodontol. 1990;17:233-42.
12. Karjalainen K, Knuuttila M. The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin-dependent diabetes mellitus. J Clin Periodontol. 1996;23:1060-7.
13. Ervasti T, Knuuttila M, Pohjamo L, et al. Relation between control of diabetes and gingival bleeding. J Periodontol. 1985;56:154-7.
14. Cutler C, Machen R, Jotwani R, et al. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol. 1999;70:1313-21.
15. Lalla E, Park D, Papapanou P, et al. Oral disease burden in Northern Manhattan patients with diabetes mellitus. Am J Public Health. 2004;94:755-8.
16. Lalla E, Cheng B, Lal S, et al. Diabetes-related parameters and periodontal conditions in children. J Periodontal Res. 2007;42: 345-9.
17. Tervonen T, Oliver R. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol. 1993;20:431-5.
18. Guzman S, Karima M, Wang H-Y, et al. Association between interleukin-1 genotype and periodontal disease in a diabetic population. J Periodontol. 2003;74:1183-90.
19. Taylor G, Burt B, Becker M, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol. 1998;69:76-83.
20. Westfelt E, Rylander H, Blohmé G, et al. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996;23:92-100.
21. Karjalainen K, Knuuttila M, von Dickhoff K. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol. 1994;65:1067-72.
22. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status.A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol. 1997;24:505-10.
23. Ryder M. Anatomy, development, and physiology of the periodontium. In: Rose L, Mealey B, editors. Periodontics medicine, surgery, and implants. St. Louis: Elsevier Mosby; 2004.
24. Grant D, Stern B, Everett F. Orban's periodontics: a concept- theory and practice. Saint Louis: Mosby; 1972.
25. Page R, Offenbacher S, Schroeder H, et al. Advances in the pathogenesis of periodontitis. Summary of developments, clinical implications and future directions. Periodontol 2000. 1997;14:12-32.
26. Page R, Schroeder H. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976;34:235-49.
27. Oliver R, Brown L, Loe H. Periodontal diseases in the United States population. J Periodontol. 1998;69:269-78.
28. Lindhe J, Okamoto H, Yoneyama T, et al. Longitudinal changes in periodontal disease in untreated subjects. J Clin Periodontol. 1989;16:662-70.
29. Kornman K. Patients are not equally susceptible to periodontitis. Does this change dental practice and dental curriculum? J Dent Educ. 2001;65:777-84.
30. Machtei E, Hausmann E, Dunford R, et al. Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol. 1999;26:374-80.
31. Burt B. American Academy of Periodontology Position paper: epidemiology of periodontal diseases. J Periodontol. 2005;76:1406-19.
32. Lang N, Tonetti M, Suter J, et al. Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodont Res. 2000;35:102-7.
33. Muller H, Stadermann S, Heinecke A. Longitudinal association between plaque and gingival bleeding in smokers and nonsmokers. J Clin Periodontol. 2002;29:287-94.
34. Deinzer R, Forster P, Fuck L, et al. Increase of crevicular interleukin 1-beta under academic stress at experimental gingivitis sites and at sites of perfect oral hygiene. J Clin Periodontol. 1999;26:1-8.
35. Baelum V. Pattern of periodontal breakdown in adult Tanzanians. Scand J Dent Res. 1987;95:221-8.
36. Baelum V, Fejerskov O, Manji F. Periodontal diseases in adult Kenyans. J Clin Periodontol. 1988;15:445-52.
37. Emrich L, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991;62:123-30.
38. Guzman S, Karima M, Wang H-Y, et al. Association between interleukin-1 genotype and periodontal disease in a diabetic population. J Periodontol. 2003;74:1183-90.
39. Tervonen T, Knuuttila M. Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Surg Oral Med Oral Pathol. 1986;61:346-9.
40. Safkan-Seppala B, Ainamo J. Periodontal conditions in insulindependent diabetes mellitus. J Clin Periodontol. 1992;19:24-9.
41. Seppala B, Seppala M, Ainamo J. A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease. J Clin Periodontol. 1993;20:161-5.
42. Seppala B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol. 1994;21:161-5.
43. Tsai C, Hayes C, Taylor G. Glycemic control of type 2 diabetes and severe periodontal disease in the U.S. adult population. Community Dent Oral Epidemiol. 2002;30:182-92.
44. Taylor G, Burt B, Becker M, et al. Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol. 1998;3:30-9.
45. Sastrowijoto S, Hillemans P, Van Steenbergen T, et al. Periodontal condition and microbiology of healthy and diseased periodontal pockets in type 1 diabetes mellitus patients. J Clin Periodontol. 1989;16:316-22.
46. Zambon J, Reynolds H, Fisher J, et al. Microbiological and immunological studies of adult periodontitis in patients with non-insulin dependent diabetes mellitus. J Periodontol. 1988;59:23-31.
47. Sbordone L, Ramaglia L, Barone A, et al. Periodontal status and subgingival microbiota of insulin-dependent juvenile diabetics: a 3-year longitudinal study. J Periodontol. 1998;69:120-8.
48. Manouchehr-Pour M, Spagnuolo P, Rodman H, et al. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981;52:410-5.
49. McMullen J, Van Dyke T, Horoszewicz H, et al. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol. 1981;52:167-73.
50. Schmidt A, Yan S, Wautier J-L, et al. Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84:489-97.
51. Schmidt A, Hori O, Cao R, et al. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 1996;45 Suppl 3:S77-80.
52. Loder R. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop. 1988;232:210-6.
53. Inaba M, Nishizawa Y, Mita K, et al. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1, 25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int. 1999;9:525-31.
54. Tisdel C, Marcus R, Heiple K. Triple arthrodesis for diabetic peritalar neuroarthropathy. Foot Ankle Int. 1995;16:332-8.
55. White C, Turner N, Lee G, et al. Open ankle fractures in patients with diabetes mellitus. Clin Orthop. 2003;414:37-44.
56. Beam H, Parsons J, Lin S. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res. 2002;20:1210-6.
57. Gooch H, Hale J, Fujioka H, et al. Alterations of cartilage and collagen expression during fracture healing in experimental diabetes. Connect Tissue Res. 2000;41:81-5.
58. Lu H, Kraut D, Gerstenfeld L, et al. Diabetes interferes with bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2003;144:346-52.
59. He H, Liu R, Desta T, et al. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology. 2004;145:447-52.
60. Liu R, Desta T, He H, et al. Diabetes alters the response to bacteria by enhancing fibroblast apoptosis. Endocrinology. 2004;145:2997-3003.
61. Liu R, Bal H, Desta T, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006;85:510-4.
62. Nishimura F, Takahashi K, Kurihara M, et al. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol. 1998;3:20-9.
63. Schmidt A, Weidman E, Lalla E, et al. Advanced glycation end products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontol Res. 1996;31:508-15.
64. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 1997;23:125-30.
65. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res. 2000;53:53-67.
66. Unlu F, Gurdal Guneri P, Hekimgil M, et al. Expression of vascular endothelial growth factor in human periodontal tissues: comparison of healthy and diabetic patients. J Periodontol. 2003;74:181-7.
67. Taylor G, Burt B, Becker M, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67(10 Suppl):1085-93.
68. Grossi S, Genco R. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol. 1998;3:51-61.
69. Taylor G, Burt B, Becker M, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol. 1998;69:76-83.
70. Lalla E, Lamster I, Drury S, et al. Hyperglycemia, glycoxidation and receptor for advanced glycation end products: potential mechanisms underlying diabetic complications, including diabetesassociated periodontitis. Periodontol 2000. 2000;23:50-62.
71. Soskolne W, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol. 2001;6: 91-8.
72. Taylor G. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001;6(1):99-112.
73. Grossi S, Skrepcinski F, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997;68:713-9.
74. Kiran M, Arpak N, Unsal E, et al. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005;32:266-72.
75. Faria-Almeida R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol. 2006;77:591-8.
76. Stewart J, Wager K, Friedlander A, et al. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. Clin Periodontol. 2001;28:306-10.
77. Page R, Offenbacher S, Schroeder H, et al. (1997) Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol. 2000;14:216-48.
78. Salvi G, Brown C, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontol. 1998;33:212-25.
79. Iehara N, Takeoka H, Yamada Y, et al. Advanced glycation end products modulate transcriptional regulation in mesangial cells. Kidney Int. 1996;50:1166-72.
80. Brownlee M. The pathological implications of protein glycation. Clin Invest Med. 1995;18:275-81.
81. Tanimoto K, Ohno S, Fujimoto K, et al. Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultural rabbit synovial membrane cells. Connect Tissue Res. 2001;42:187-96.
82. Lalla E, Lamster I, Stern D, et al. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol. 2001;6:113-8.
83. Tan K, Chow W, Tam S, et al. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care. 2004;27:223-8.
84. Jambou D, Dejour N, Bayer P, et al. Effect of human native lowdensity and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P338D1: possible implication in pathogenesis of atherosclerosis. BiochimBiophys Acta. 1993;1168:115-21.
85. Salback PB, Specht E, von Hodenberg E, et al. Differential low density lipoprotein receptor-dependent formation of eicosanoids in human blood-derived monocytes. Proc Nat Acad Sci (USA). 1992;89:2439-43.
86. Offenbacher S. Periodontal diseases: pathogenesis (review). Ann Periodontol. 1996;1:821-78.
87. Schmidt A, Hort O, Brett J, et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 1994;14:1521-8.
88. Raynes J. The active phase response. Biochem Soc Trans. 1994;22:69-74.
89. Paz K, Hemi R, LeRoith D, et al. A molecular basis for insulin resistance-elevated serine/threonin phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem. 1997;272:29911-8.
90. Yoshimura A, Kaneko T, Kato Y, et al. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human Toll-like receptor 4. Infect Immun. 2002;70:218-25.
91. Ogawa T, Asai Y, Hashimoto M, et al. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol. 2002;14:1325-32.
92. Streja D, Cressey P, Rabkin S. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003;17:120-7.
93. Black P. The inflammatory response in an integral part of the stress response: implications for atherosclerosis, insulin resistance, type 2 diabetes and metabolic syndrome X. Behav Immun. 2003;17:350-64.
94. Soory M. Hormone mediation of immune responses in the progression of diabetes, rheumatoid arthritis and periodontal diseases. Curr Drug Targets-Immune, Endocrine Metab Disorders. 2002;2:13-25.
95. Suppipat N, Suppipat N. Evaluation of an electronic device for gingival fluid quantitation. J Periodontol. 1977;48:388-94.
96. Hinrichs J, Bandt C, Smith J, et al. A comparison of 3 systems for quantifying gingival crevicular fluid with respect to linearity and the effects of qualitative differences in fluids. J Clin Periodontol. 1984;11:652-61.
97. Williams R, Pacquette D. Advances in periodontal diagnosis. In: Lindhe J, Karring T, Lang NP, editors. Clinical periodontology and implant dentistry. 3rd ed. Copenhagen: Munksgaard; 1997.
98. Offenbacher S, Farr D, Goodson J. Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol. 1981;8:359-67.
99. Lamster I, Oshrain R, Harper D, et al. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis. Six month results. J Periodontol. 1988;59:516-23.
100. Palcanis K, Larjava I, Wells B, et al. Elastase as an indicator of periodontal disease progression. J Periodontol. 1992;63:237-42.
101. Kinane D. Regulators of tissue destruction and homeostasis as diagnostic aids in periodontology. Periodontology 2000. 2000;24:215-25.
102. Embery G, Waddington R, Hall R, et al. Connective tissue elements as diagnostic aids in periodontology. Periodontology 2000. 2000;24:193-214.
103. Strauss S, Wheeler A, Russell S, et al. The potential use of gingival crevicular blood for measuring glucose to screen for diabetes: an examination based on characteristics of the blood collection site. J Periodontol. 2009;80:907-14.
104. Yamaguchi M, Kambe S, Yamazaki K, et al. Error grid analysis of noninvasive glucose monitoring via gingival crevicular fluid. IEEE Trans Biomed Eng. 2005;52:1796-8.
105. Yamaguchi M, Takada R, Kambe S, et al. Evaluation of timecourse changes of gingival crevicular fluid glucose levels in diabetics. Biomed Microdevices. 2005;7:53-8.
106. Yamaguchi M, Kawabata Y, Kambe S, et al. Non-invasive monitoring of gingival crevicular fluid for estimation of blood glucose level. Med Biol Eng Comput. 2004;42:322-7.
107. Khader Y, Al-Zubi B, Judeh A, et al. Screening for type 2 diabetes mellitus using gingival crevicular blood. Int J Dent Hygiene. 2006;4:179-82.
108. Beikler T, Kuczek A, Petersilka G, et al. In-dental-office screening for diabetes mellitus using gingival crevicular blood. J Clin Periodontol. 2002;29:216-8.
109. Müller H, Behbehani E. Screening of elevated glucose levels in gingival crevice blood using a novel, sensitive self-monitoring device. Med Princ Pract. 2004;13:361-5.
110. Müller H, Behbehani E.Methods formeasuring agreement: glucose levels in gingival crevice blood. Clin Oral Investig. 2005;9:65-9.
111. Ardakani M, Moeintaghavi A, Haerian A, et al. Correlation between levels of sulcular and capillary blood glucose. J Contemp Dent Pract. 2009;10:10-7.
112. Ficara A, Levin M, Grower M, et al. A comparison of the glucose and protein content of gingival crevicular fluid from diabetics and nondiabetics. J Periodont Res. 1975;10:171-5.
113. Parker R, Rapley J, Isley W, et al. Gingival crevicular blood for assessment of blood glucose in diabetic patients. J Periodontol. 1993;64(7):666-72.
114. Ciantar M, Spratt D, Newman H, et al. Development of an in vitro microassay for glucose quantification in submicrolitre volumes of biological fluid. J Periodont Res. 2002;37:79-85.
115. Safkan-Seppälä B, Sorsa T, Tervahartiala T, et al. Collagenases in gingival crevicular fluid in type 1 diabetes mellitus. J Periodontol. 2006;77:189-94.
116. Gursoy U, Marakoglu I, Ersan S. Periodontal status and cytoplasmic enzyme activities in gingival crevicular fluid of type 2 diabetic and/or obese patients with chronic periodontitis. J Int Acad Periodontol. 2006;8:2-5.
117. Engebretson S, Hey-Hadavi J, Ehrhardt F, et al. Gingival crevicular fluid levels of interleukin-1β and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol. 2004;75:1203-8.
118. Hou L, Liu C, Rossomando E. Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol. 1995;22:162-7.
119. Tsai C, Ho Y, Chen C. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol. 1995;66:852-9.
120. Orozco A, Gemmell E, Bickel M, et al. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol. 2006;21:256-60.
121. Salvi G, Beck J, Offenbacher S. PGE2, IL-1 β, and TNF-α responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol. 1998;3:40-50.
122. Bulut U, Develioglu H, Taner IL, et al. Interleukin-1 beta levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis. J Oral Sci. 2001;43:171-7.
123. Engebretson S, Grbic J, Singer R, et al. GCF IL-1b profiles in periodontal disease. J Clin Periodontol. 2002;29:48-53.
124. Zhong Y, Slade G, Beck J, et al. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol. 2007;34:285-93.
125. Andriankaja O, Barros S, Moss K, et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1β and prostaglandin E2 among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol. 2009;80:307-16.
126. Kardeşler L, Buduneli N, Biyikoglu B, et al. Gingival crevicular fluid PGE2, IL-1β, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin Biochem. 2008;41:863-8.
127. Güneri P, Ünlü F, Yeşilbek B, et al. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol. 2004;75:91-7.
128. Prapulla D, Sujatha P, Pradeep A. Gingival Crevicular Fluid VEGF Levels in Periodontal Health and Disease. J Periodontol. 2007;78:1783-7.
129. Sakallioglu E, Aliyev E, Lütfioglu M, et al. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig. 2007;11:115-20.
130. Heasman P, Collins J, Offenbacher S. Changes in crevicular fluid levels of interleukin-1, beta leukotriene B4, prostaglandin E2, thromboxane B2 and tumour necrosis factor alpha in experimental gingivitis in humans. J Periodontal Res. 1993;28:241-7.
131. Offenbacher S, Odle B, Van Dyke T. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res. 1986;21:101-12.
132. Gurkan A, Emingil G, Cinarcik S, et al. Gingival crevicular fluid transforming growth factor-β1 in several forms of periodontal disease. Arch Oral Biol. 2006;51:906-12.
133. Schierano G, Pejrone G, Brusco P, et al. TNF-α, TGF-β2 and IL-1β levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. J Clin Periodontol. 2008;35:532-8.
134. Masada M, Persson R, Kenny J, et al. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res. 1990;25:156-63.
135. Mathur A, Michalowicz B, Castillo M, et al. Interleukin-1 alpha, interleukin-8 and interferon-alpha levels in gingival crevicular fluid. J Periodontal Res. 1996;31:489-95.
136. Tsalikis L, Parapanisiou E, Bata-Kyrkou A, et al. Crevicular fluid levels of interleukin-1alpha and interleukin-1beta during experimental gingivitis in young and old adults. J Int Acad Periodontol. 2002;4:5-11.
137. Kurtis B, Develioglu H, Taner I, et al. IL-6 levels in gingival crevicular fluid (GCF) from patients with non-insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects. J Oral Sci. 1999;41:163-7.
138. Giannopoulou C, Bernard J, Buser D, et al. Effect of intracrevicular restoration margins on peri-implant health: clinical, biochemical, and microbiologic findings around esthetic implants up to 9 years. Int J Oral Maxillofac Implants. 2003;18:173-81.
139. Borg Andersson A, Birkhed D, Berntorp K, et al. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. Eur J Oral Sci. 1998;106:931-7.
140. Arana C, Cutando A, Ferrera M, et al. Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med. 2006;35:554-9.
141. Gumus P, Buduneli N, Cetinkalp S, et al. Salivary antioxidants in patients with type 1 or type 2 diabetes and inflammatory periodontal disease: a case-control study. J Periodontol. 2009;80:1440-6.
142. Figueredo C, Ribeiro M, Fischer R, et al. Increased interleukin-1β concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol. 1999;70:1457-63.
143. Gonzales J, Herrmann J, Boedeker R, et al. Concentration of interleukin-1β and neutrophil elastase activity in gingival crevicular fluid during experimental gingivitis. J Clin Periodontol. 2001;28:544-9.
144. Faizuddin M, Bharathi S, Rohini N. Estimation of interleukin-1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodont Res. 2003;38:111-4.
145. Skateric U, Kramar B, Petelin M, et al. Changes inTGFβ1levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Sci. 1997;105:136-42.
146. Buduneli N, Kutukculer N, Aksu G, et al. Evaluation of transforming growth factor -β1 level in crevicular fluid of cyslosporin A-treated patients. J Periodontol. 2001;72:526-31.
147. Wright H, Chapple I, Matthews J. Levels of TGFβ1 in gingival crevicular fluid during a 21-day experimental model of gingivitis. Oral Dis. 2003;9:88-94.
148. Kuru L, Griffiths G, Petrie A, et al. Changes in transforming growth factor-β1 in gingival crevicular fluid following periodontal surgery. J Clin Periodontol. 2004;31:527-33.
149. Gurkan A, Cinarcik S, Huseyinov A. Adjunctive subantimicrobial dose doxycycline:effect on clinical parameters and gingival crevicular fluid transforming growth factor b1levels in severe, generalized chronic periodontitis. J Clin Periodontol. 2005;32:244-53.
150. Golubnitschaja O, Jaksche A, Moenkemann H, et al. Molecular imaging system for possible prediction of active retinopathy in patients with diabetes mellitus. Amino Acids. 2005;28:229-37.